Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events

04.06.20141515
Patients with chest pain and no obstructive coronary artery disease (CAD) are considered at low risk for cardiovascular events but evidence supporting this is scarce.

Stopping statins for terminal patients doesn't hasten death and may improve their quality of life, a trial showed.

03.06.20141322
The 60-day mortality rate didn't differ significantly after discontinuation of long-standing statin therapy compared with staying on it,Amy Abernethy, MD, PhD, of Duke University Medical Center, and colleagues found.

Diabetes as Risk Factor for Incident Coronary Heart Disease in Women Compared With Men: A Systematic Review and Meta-Analysis of 64 Cohorts Including 858,507 Individuals and 28,203 Coronary Events

02.06.20141719
This meta-analysis used PubMed to identify prospective population-based cohort studies published between January 1, 1966 and February 13, 2013.

External CME credits for participation in the Russian Cardiovascular Days

01.06.20142517
Russian Cardiovascular Days is the first RSC meeting accredited in the project of the Ministry of Health of the Russian Federation on continuous medical education (CME).

Vitamin, Mineral, and Multivitamin Supplements for the Primary Prevention of Cardiovascular Disease and Cancer: U.S. Preventive Services Task Force Recommendation Statement

30.05.20141456
What are the updates from the 2003 U.S. Preventive Services Task Force (USPSTF) recommendations on vitamin supplements to prevent cardiovascular disease and cancer?

More Brain Bleeds With Stroke Drug in 'Real World'

29.05.20141379
In a real-world practice setting, the use of tissue plasminogen activator (tPA, Alteplase) results in a higher rate of intracerebral hemorrhage than was seen in the well-controlled clinical trials that led to widespread use of the treatment in stroke patients, researchers said here.

Temporal Trends in the Use of High-Dose Potent Statins following Acute Coronary Syndrome in Israel

28.05.20142007
This study aimed to evaluate factors associated with the prescription of high-dose potent statin (HDPS) therapy following hospitalization for acute coronary events.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.